The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nichols Weston since 2023.
This trader's CIK number is 1746376.
At the time of last reporting, Nichols Weston was the Officer of Passage Bio, Inc.. (stock ticker symbol PASG).
Also see all insider trading activities at Passage Bio, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TCRX | 2,588,794 | $3,106,552 | 0 | $0 | 0 | $0 |
| 2024 | TCRX | 947 | $4,113 | 0 | $0 | 0 | $0 |
| 2023 | TCRX | 0 | $0 | 25,400 | $63,855 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PASG | 128,848 | $733,852 | 0 | $0 | 0 | $0 |
| 2024 | PASG | 829,998 | $525,573 | 0 | $0 | 0 | $0 |
1. Tscan Therapeutics, Inc. (TCRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-19 | TCRX | Buy | 1,388,794 | 1.20 | 1,666,552 |
| 2025-05-20 | TCRX | Buy | 1,200,000 | 1.20 | 1,440,000 |
| 2024-11-15 | TCRX | Buy | 947 | 4.34 | 4,113 |
| 2023-05-31 | TCRX | Sale | 25,400 | 2.51 | 63,855 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-24 | PASG | Buy | 66,423 | 5.71 | 379,474 |
| 2025-07-22 | PASG | Buy | 13,123 | 5.44 | 71,336 |
| 2025-07-23 | PASG | Buy | 49,302 | 5.74 | 283,042 |
| 2024-12-27 | PASG | Buy | 373,645 | .65 | 241,001 |
| 2024-11-25 | PASG | Buy | 259,998 | .56 | 146,638 |
| 2024-11-26 | PASG | Buy | 167,055 | .71 | 118,274 |
| 2024-11-27 | PASG | Buy | 29,300 | .67 | 19,660 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nichols Weston (Officer of Passage Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.